P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation

Oncogene

Volumn 23, Issue 45, 2004, Pages 7537-7544

  Casanovas, Oriol ^a   Jaumot, Montserrat ^a   Paules, Ana Belén ^a   Agell, Neus ^a   Bachs, Oriol ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cancer; Cell cycle; Cyclin D3; p38SAPK; Proteasome

Indexed keywords

CYCLIN D3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN SERINE THREONINE KINASE; THREONINE; CYCLINE; CYSTEINE PROTEINASE; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MULTIENZYME COMPLEX; PRIMER DNA; RECOMBINANT PROTEIN; UBIQUITIN;

ARTICLE; CARCINOGENESIS; CELL MATURATION; ENZYME ANALYSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; STRESS; T LYMPHOCYTE; UBIQUITINATION; CHEMISTRY; HYDROLYSIS; METABOLISM; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLINS; CYSTEINE ENDOPEPTIDASES; DNA PRIMERS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYDROLYSIS; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIENZYME COMPLEXES; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; THREONINE; UBIQUITIN;

EID: 6344240450     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208040     Document Type: Article

References (44)

1. Bagui TK, Mohapatra S, Haura E and Pledger WJ. (2003). Mol. Cell. Biol. 23, 7285-7290.
2. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, Appella E and Fornace Jr AJ. (2001). Nature, 411, 102-107.
3. Buschges R, Weber RG, Actor B, Lichter P, Collins VP and Reifenberger G. (1999). Brain Pathol., 9, 435-442.
4. Casanovas O, Miro F, Estanyol JM, Itarte E, Agell N and Bachs O. (2000). J. Biol. Chem., 275, 35091-35097.
5. Chen Q, Lin J, Jinno S and Okayama H. (2003). Oncogene, 22, 992-1001.
6. Ciemerych MA, Kenney AM, Sicinska E, Kalaszczynska I, Bronson RT, Rowitch DH, Gardner H and Sicinski P. (2002). Genes Dev., 16, 3277-3289.
7. Diehl JA, Cheng M, Roussel MF and Sherr CJ. (1998). Genes Dev., 12, 3499-3511.
8. Diehl NL, Enslen H, Fortner KA, Merritt C, Stetson N, Charland C, Flavell RA, Davis RJ and Rinc inverted question mM. (2000). J. Exp. Med., 191, 321-334.
9. Fantl V, Stamp G, Andrews A, Rosewell I and Dickson C. (1995). Genes Dev., 9, 2364-2372.
10. Filipits M, Jaeger U, Pohl G, Stranzl T, Simonitsch I, Kaider A, Skrabs C and Pirker R. (2002). Clin. Cancer Res., 8, 729-733.
11. Florenes VA, Faye RS, Maelandsmo GM, Nesland JM and Holm R. (2000). Clin. Cancer Res., 6, 3614-3620.
12. Graña X and Reddy PE. (1995). Oncogene, 11, 211-219.
13. Guan KL and Dixon JE. (1991). Anal. Biochem., 192, 262-267.
14. Gutzkow KB, Lahne HU, Naderi S, Torgersen KM, Skalhegg B, Koketsu M, Uehara Y and Blomhoff HK. (2003). Cell Signal., 15, 871-881.
15. Hedberg Y, Roos G, Ljungberg B and Landberg G. (2002). Acta Oncol., 41, 175-181.
16. Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I and Zuckerman KS. (2002). J. Biol. Chem., 277, 16528-16537.
17. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ and Look AT. (1992). Genomics, 13, 565-574.
18. Ito Y, Takeda T, Wakasa K, Tsujimoto M and Matsuura N. (2001). Anticancer Res., 21, 1043-1048.
19. Iyoda K, Sasaki Y, Horimoto M, Toyama T, Yakushijin T, Sakakibara M, Takehara T, Fujimoto J, Hori M, Wands JR and Hayashi N. (2003). Cancer, 97, 3017-3026.
20. Jaumot M, Estanyol JM, Serratosa J, Agell N and Bachs O. (1999). Hepatology, 29, 385-395.
21. Kumar S, Boehm J and Lee JC. (2003). Nat. Rev. Drug Discov., 2, 717-726.
22. Ma Y, Croxton R, Moorer RLJ and Cress WD. (2002). Arch. Biochem. Biophys., 399, 212-224.
23. Ma Y, Yuan J, Huang M, Jove R and Cress WD. (2003). J. Biol. Chem., 278, 16770-16776.
24. Matsushime H, Roussel MF and Sherr CJ. (1991). Cold Spring Harb. Symp. Quant. Biol., 56, 69-74.
25. Mayol X, Garriga J and Grana X. (1995). Oncogene, 11, 801-808.
26. Morgan DO. (1997). Annu. Rev. Cell Dev. Biol., 13, 261-291.
27. Morin CI and Huot J. (2004). Cancer Res., 64, 1893-1898.
28. Neet K and Hunter T. (1995). Mol. Cell. Biol., 15, 4908-4920.
29. Olson JM and Hallahan AR. (2004). Trends Mol. Med., 10, 125-129.
30. Pirkmaier A, Dow R, Ganiatsas S, Waring P, Warren K, Thompson A, Hendley J and Germain D. (2003). Oncogene, 22, 4425-4433.
31. Rickheim DG, Nelsen CJ, Fassett JT, Timchenko NA, Hansen LK and Albrecht JH. (2002). Hepatology, 36, 30-38.
32. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF and Ohashi PS. (1999). Annu. Rev. Immunol., 17, 829-874.
33. Sen J, Kapeller R, Fragoso R, Sen R, Zon LI and Burakoff SJ. (1996). J. Immunol., 156, 4535-4538.
34. Shaughnessy Jr J, Gabrea A, Qi Y, Brents L, Zhan F, Tian E, Sawyer J, Barlogie B, Bergsagel PL and Kuehl M. (2001). Blood, 98, 217-223.
35. Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H and Sicinski P. (2003). Cancer Cell, 4, 451-461.
36. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ and Weinberg RA. (1996). Nature, 384, 470-474.
37. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ and Weinberg RA. (1995). Cell, 82, 621-630.
38. Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberger B, Sole F, Mungall AJ, Gascoyne RD, Siebert R and Dyer MJ. (2001). Blood, 98, 2837-2844.
39. Tao GZ, Rott LS, Lowe AW and Omary MB. (2002). J. Biol. Chem., 277, 19295-19303.
40. Wada T and Penninger JM. (2004). Oncogene, 23, 2838-2849.
41. Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B and Pestell RG. (1998). Mol. Cell. Biol., 18, 3212-3222.
42. Weinberg RA. (1995). Cell, 81, 323-330.
43. Xiao ZX, Ginsberg D, Ewen M and Livingston DM. (1996). Proc. Natl. Acad. Sci. USA, 93, 4633-4637.
44. Xiong Y, Menninger J, Beach D and Ward DC. (1992). Genomics, 13, 575-584.